Eli Lilly seems to have responded to the threat by President Donald Trump of tariffs on the pharma industry if they don't relocate their manufacturing operations to the US. The pharma group has just ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

Supreme Court Refuses to Allow National Guard Deployment in Chicago The move signaled that the justices are likely to immediately block similar deployments in other American cities. Student Loan ...

If you’ve ever noticed the rising costs and falling standards that seem to be endemic in industries like healthcare, housing, ...